Imaging for Uterine Myomas and Adenomyosis

Journal of Minimally Invasive Gynecology

Volumn 21, Issue 3, 2014, Pages 362-376

  Shwayder, James ^a   Sakhel, Khaled ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Adenomyosis; CT; Doppler; Elastography; Leiomyoma; Leiomyosarcoma; MRI; Myoma; Ultrasound

Indexed keywords

AROMATASE INHIBITOR; GESTAGEN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; PROGESTERONE RECEPTOR MODULATOR;

ADENOMYOSIS; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE MARKER; ECHOGRAPHY; ELASTOGRAPHY; FEMALE INFERTILITY; HETEROGENEOUS ECHO TEXTURE; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HYSTERECTOMY; IMAGING; INTRAUTERINE CONTRACEPTIVE DEVICE; LAPAROSCOPIC SURGERY; MENORRHAGIA; MYOMECTOMY; MYOMETRIAL BORDER; MYOMETRIUM; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDUNCULATED MYOMA; PELVIC PAIN; POLLAKISURIA; POSITRON EMISSION TOMOGRAPHY; PREGNANCY; RETROPERITONEUM; REVIEW; ROBOTICS; SONOHYSTEROGRAPHY; SUBENDOMETRIAL ECHOGENIC LINEAR STRIATION; SYMPTOM; THICKENING OF THE TRANSITION ZONE; THREE DIMENSIONAL IMAGING; TRANSVAGINAL ECHOGRAPHY; TUMOR DIFFERENTIATION; URETER OBSTRUCTION; UTERINE ARTERY EMBOLIZATION; UTERINE ENLARGEMENT; UTERINE WALL THICKENING; UTERUS BLEEDING; UTERUS DISEASE; UTERUS MYOMA; DYSMENORRHEA; FEMALE; LEIOMYOMA; MIDDLE AGED; MYOMA; PELVIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; UTERINE NEOPLASMS;

ADENOMYOSIS; DYSMENORRHEA; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; LEIOMYOMA; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MYOMA; PELVIS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, COLOR; UTERINE NEOPLASMS;

EID: 84899958267     PISSN: 15534650     EISSN: 15534669     Source Type: Journal    
DOI: 10.1016/j.jmig.2013.11.011     Document Type: Review

References (91)

1. Cramer S., Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990, 94:435-438.
2. Bazot M., Daraï E., Rouger J., Detchev R., Cortez A., Uzan S. Limitations of transvaginal sonography for the diagnosis of adenomyosis, with histopathological correlation. Ultrasound Obstet Gynecol 2002, 20:605-611.
3. Botsis D., Kassanos D., Antoniou G., Pyrgiotis E., Karakitsos P., Kalogirou D. Adenomyoma and leiomyoma: differential diagnosis with transvaginal sonography. J Clin Ultrasound 1998, 26:21-25.
4. Lurie S., Piper I., Woliovitch I., Glezerman M. Age-related prevalence of sonographically confirmed uterine myomas. J Obstet Gynecol 2005, 24:42-44.
5. Wise L.A., Palmer J.R., Stewart E.A., Rosenberg L. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol 2005, 105:563-568.
6. Kjerulff K., Langenberg P., Seidman J., Stolley P., Guzinski G. Uterine leiomyomas: racial differences in severity, symptoms and age at diagnosis. J Reprod Med 1996, 41:483-490.
7. Bouyer J., Job-Spira N., Pouly J., Coste J., Germain E., Fernandez H. Fertility following radical, conservative-surgical or medical treatment for tubal pregnancy: a population-based study. BJOG 2000, 107:714-721.
8. Evans P., Brunsell S. Uterine fibroid tumors: diagnosis and treatment. Am Fam Physician 2007, 75:1503-1508.
9. Hashimoto K., Azuma C., Kamiura S., et al. Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene. Gynecol Obstet Invest 1995, 40:204-208.
10. Parker W.F., Fu Y.S., Berek J.S. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 1994, 83:414-418.
11. Munro M.C., Critchley H.O., Fraser I. FIGO Menstrual Disorders Working Group. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril 2011, 95:2204-2208.
12. Yoon S.-W., Lee C., Cha S.H., et al. Patient selection guidelines in MR-guided focuses ultrasound surgery of uterine fibroids: a pictorial guide to relevant findings in screening pelvic MRI. Eur Radiol 2008, 18:2997-3006.
13. Schwartz P.E., Kelly M.G. Malignant transformation of myomas: myth or reality?. Obstet Gynecol Clin North Am 2006, 33:183-198.
14. Engel J.B., Audebert A., Frydman R., Zivny J., Diedrich K. Presurgical short term treatment of uterine fibroids with different doses of cetrorelix acetate: a double-blind, placebo-controlled multicenter study. Eur J Obstet Gynecol Reprod Biol 2007, 134:225-232.
15. Friedman A.J., Barbieri R.L., Benacerraf B.R., et al. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist. Fertil Steril 1987, 48:560-564.
16. Rein M.S., Friedman A.J., Struart J.M., MacLaughlin D.T. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate. Fertil Steril 1990, 53:1018-1023.
17. Stewart E.A., Friedman A.J. Steroidal treatment of myomas: preoperative and long-term medical therapy. Semin Reprod Endocrinol 1992, 10:344-357.
18. Talaulikar V.S., Manyonda I. Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids. Eur J Obstet Gynecol Reprod Biol 2012, 165:135-140.
19. Vercellini P., Trespìdi L., Zaina B., Vicentini S., Stellato G., Crosignani P.G. Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial. Fertil Steril 2003, 79:1390-1395.
20. Munro M.G. Uterine leiomyomas, current concepts: pathogenesis, impact on reproductive heatlh, and medical, procedural, and surgical managment. Obstet Gynecol Clin North Am 2011, 38:703-731.
21. Goldfarb H.A. Myoma coagulation (myolysis). Obstet Gynecol Clin North Am 2000, 27:421-430.
22. Liu W.M. Laparoscopic bipolar coagulation of uterine vessels to treat symptomatic leiomyomas. J Am Assoc Gynecol Laparosc 2000, 7:125-129.
23. Nisolle M., Smets M., Malvaux V., Anaf V., Donnez J. Laparoscopic myolysis with the Nd:YAG laser. J Gynecol Surg 1993, 9:95-99.
24. Olive DL, Rutherford T, Zreid R, Palter S, eds. Cryomyolysis in the conservative treatment of uterine fibroids. AAGL 25th Annual Meeting; September 24-29, 1996; Chicago, Illinois.
25. Phillips D.R., Milim S.J., Nathanson H.G., Haselkron J.S. Experience with laparoscopic leiomyoma coagulation and concomitant operative hysteroscopy. J Am Assoc Gynecol Laparosc 1997, 4:425-433.
26. Zreik T.G., Rutherford T.J., Palter S.F., et al. Cryomyolysis, a new procedure for the conservative treatment of uterine fibroids. J Am Assoc Gynecol Laparosc 1998, 5:33-38.
27. Karasick S., Lev-Toaff A.S., Toaff M.E. Imaging of uterine leiomyomas. AJR Am J Roentgenol 1992, 158:799-805.
28. Pasqualotto E.B., Margossian H., Brice L.L., Bradley L.D. Accuracy of preoperative diagnositc tools and outcome of hysteroscopic managment of menstrual dysfunction. J Am Assoc Gynecol Laparosc 2000, 7:201-210.
29. Grimbizis G.F., Tsolakidis D., Mikos T., et al. A prospective comparison of transvaginal ultrasound, saline infusion sonohysterography, and diagnostic hysteroscopy in the evaluation of endometrial pathology. Fertil Steril 2010, 94:2720-2725.
30. Dueholm M., Lundorf E., Hansen E., Ledertoug S., Oleson F. Evaluation of the uterine cavity with magnetic resonance imaging, transvaginal sonography, hysterosonographic examination and diagnostic hysteroscopy. Fertil Steril 2001, 76:350-357.
31. Appleton K., Plavsic S.K. Role of ultrasound in the assessment of postmenopausal bleeding. Donald School J Ultrasound Obstet Gynecol 2012, 6:197-206.
32. Ami O., Lamazou F., Mabille M., Levaillant J.M., Deffieux X., Frydman R. Real-time transvaginal elastosonography of uterine fibroids. Ultrasound Obstet Gynecol 2009, 34:486-488.
33. Cheung V.Y.T. Sonographically guided high-intensity focused ultrasound for the managment of uterine fibroids. J Ultrasound Med 2013, 32:1353-1358.
34. Parker W. The utility of MRI for the surgical treatment of women with uterine fibroid tumors. Am J Obstet Gynecol 2012, 206:31-36.
35. Falcone T., Parker W.H. Surgical management of leiomyomas for fertility or uterine preservation. Obstet Gynecol 2013, 121:856-868.
36. Levens E.D., Wesley R., Premkumar A., Blocker W., Nieman L.K. Magnetic resonance imaging and treansvaginal ultrasound for determining fibroid burden: implications for research and clinical care. Am J Obstet Gynecol 2009, 200:537.e1-537.e7.
37. Cantuaria G., Angioli R., Frost L., Duncan R., Penalver M. Comparison of bimanual examination with ultrasound examination before hysterectomy for uterine leiomyoma. Obstet Gynecol 1998, 92:109-112.
38. Dueholm M., Lundorf E., Hansen E.S., Ledertoug S., Olesen F. Accuracy of magnetic resonance imagining and transvaginal utlrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol 2002, 186:409-415.
39. Thomason P. Uterine leiomyoma (fibroid) imaging. Medscape 2012, Accessed April 1, 2013. http://emedicine.medscape.com/article/405676-overview.
40. Hutchins F.L., Worthington-Kirsch R., Berkowitz R.P. Selective uterine artery embolization as primary treatment for symptomatic leiomyomata uteri. J Am Assoc Gynecol Laparosc 1999, 6:279-284.
41. Kirby J.M., Burrows D., Haider E., Maizlin Z., Midia M. Utility of MRI before and after uterine fibroids embolization: why to do it and what to look for. Cardiovasc Intervent Radiol 2011, 34:705-716.
42. Fennessy F., Tempany C. A review of magnetic resonance imaging-guided focused ultrasound surgery of uterine fibroids. Top Magn Reson Imaging 2006, 17:173-179.
43. American Association of Gynecologic Laparoscopists AAGL Practice Report: Practice Guidelines for the Diagnosis and Management of Submucous Leiomyomas. J Minim Invasive Gynecol 2012, 19:152-171.
44. Wamsteker K., Emanuel M.H., de Kruif J.H. Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension. Obstet Gynecol 1993, 82:736-749.
45. Pritts E., Parker W., Olive D. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009, 91:1215-1223.
46. Lasmar R.B., Xinmei Z., Indman P.D., Celeste R.K., Di Spiezio Sardo A. Feasibility of a new system of classification of submucous myomas: a multicenter study. Fertil Steril 2011, 95:2073-2077.
47. Lasmar R.B., Lasmar B.P., Celeste R.K., da Rosa D.B., DdB Depes, Lopes R.G.C. A new system to classify submucous myomas: a Brazilian multicenter study. J Minim Invasive Gynecol 2012, 19:575-580.
48. Fukuda M., Shimizu T., Fukuda K., Yomura W., Shimizu S. Transvaginal hysterosonography for differential diagnosis between submucosal and intramural myoma. Gynecol Obstet Invest 1993, 35:236-239.
49. Cicinelli E., Romano F., Anastasio P., Blasi N., Parisi C., Galantino P. Transabdominal sonohysterography, transvaginal sonography, and hysteroscopy in the evaluation of submucosal myomas. Obstet Gynecol 1995, 85:42-47.
50. Bernard J.P., Rizk E., Camatte S., Robin F., Taurelle R., Lecuru F. Saline contrast sonohysterography in the preoperative assessment of benign intrauterine disorders. Ultrasound Obstet Gynecol 2001, 17:145-149.
51. Fraser I.S., Critchley H.O.D., Munro M.G., Broder M. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Fertil Steril 2007, 87:466-476. [published correction appears in Fertil Steril. 2007;88:538].
52. Cohen D.T., Oliva E., Hahn P.F., Fuller A.F., Lee S.I. Uterine smooth-muscle tumors with unusual growth patterns: imaging with pathologic correlation. AJR 2007, 188:246-255.
53. Altinok G., Usubutun A., Kucukali T., et al. Disseminated peritoneal leiomyomatosis: a benign entity mimicking carcinomatosis. Arch Gynecol Obstet 2000, 264:54-55.
54. Abramson S., Gilkeson R., Goldstein J., Woodard P., Eisenberg R., Abramson N. Benign metastasizing leiomyoma: clinical, imaging, and pathologic correlation. AJR 2001, 176:1409-1413.
55. Naohiko U., Tetsuji T., Masato M. Positron emission tomography with 18F-FDG of uterine sarcoma: a comparison with magneetic resonance imaging and power Doppler imaging. Gynecol Oncol 2001, 80:372-377.
56. Azziz R. Adenomyosis: current perspectives. Obstet Gynecol Clin North Am 1989, 16:221-235.
57. McElin T.W., Bird C.C. Adenomyosis of the uterus. Obstet Gynecol Annu 1974, 3:425-441.
58. Vercellini P., Ragni G., Trespidi L., Oldani S., Panazza S., Crosignani P.G. Adenomyosis: deja vu?. Obstet Gynecol Surv 1993, 48:789-794.
59. Bergholt T., Eriksen L., Berendt N., Jacobsen M., Hertz J.B. Prevalence and risk factors of adenomyosis at hysterectomy. Hum Reprod 2001, 16:2418-2421.
60. Farquhar C., Brosens I. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol 2006, 20:603-616.
61. Uduwela A.S., Perera M.A., Aiqing L., Fraser I.S. Endometrial-myometrial interface: relationship to adenomyosis and changes in pregnancy. Obstet Gynecol Surv 2000, 55:390-400.
62. Katz V.L. Benign gynecologic lesions: vulva, vagina, cervix, uterus, oviduct, ovary. Comprehensive Gynecology 2007, Mosby Elsevier, Philadelphia, PA, chapter 18. 5th ed. V.L. Katz, G.M. Lentz, R.A. Lobo, D.M. Gershenson (Eds.).
63. Bragheto A. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging. Contraception 2007, 76:195-199.
64. Garcia L., Isaacson K. Adenomyosis: review of the literature. J Minim Invasive Gynecol 2011, 18:425-437.
65. Fukunishi H., Funaki K., Sawada K., Yamaguchi K., Maeda T., Kaji Y. Early results of magnetic resonance-guided focused ultrasound surgery of adenomyosis: analysis of 20 cases. J Minim Invasive Gynecol 2008, 15:571-579.
66. Kim M.D., Kim S., Kim N.K., et al. Long-term results of uterine artery embolization for symptomatic adenomyosis. AJR Am J Roentgenol 2007, 188:176-181.
67. Kitamura Y., Allison S.J., Jha R.C., Spies J.B., Flick P.A., Ascher S.M. MRI of adenomyosis: changes with uterine artery embolization. AJR Am J Roentgenol 2006, 186:855-864.
68. McCausland V., McCausland A. The response of adenomyosis to endometrial ablation/resection. Hum Reprod Update 1998, 4:350-359.
69. Pelage J.P., Jacob D., Fazel A., et al. Midterm results of uterine artery embolization for symptomatic adenomyosis: initial experience. Radiology 2005, 234:948-953.
70. Rabinovici J., Inbar Y., Eylon S.C., Schiff E., Hananel A., Freundlich D. Pregnancy and live birth after focused ultrasound surgery for symptomatic focal adenomyosis: a case report. Hum Reprod 2006, 21:1255-1259.
71. Wang P.H., Liu W.M., Fuh J.L., Cheng M.H., Chao H.T. Comparison of surgery alone and combined surgical-medical treatment in the management of symptomatic uterine adenomyoma. Fertil Steril 2009, 92:876-885.
72. Wood C. Surgical and medical treatment of adenomyosis. Hum Reprod Update 1998, 4:323-336.
73. Wood C. Adenomyosis: difficult to diagnose, and difficult to treat. Diagn Ther Endosc 2001, 7:89-95.
74. Lee J.K., Gersell D.J., Balfe D.M., Worthington J.L., Picus D., Gapp G. The uterus: in vitro MR-anatomic correlation of normal and abnormal specimens. Radiology 1985, 157:175-179.
75. Reinhold C., Tafazoli F., Mehio A., et al. Uterine adenomyosis: endovaginal US and MR imaging features with histopathologic correlation. Radiographics 1999, 19 Spec No: S147-160.
76. Bazot M., Cortez A., Darai E., et al. Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology. Hum Reprod 2001, 16:2427-2433.
77. Dueholm M., Lundorf E., Hansen E.S., Sorensen J.S., Ledertoug S., Olesen F. Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis. Fertil Steril 2001, 76:588-594.
78. Chopra S., Lev-Toaff A.S., Ors F., Bergin D. Adenomyosis:common and uncommon manifestations on sonography and magnetic resonance imaging. J Ultrasound Med 2006, 25:617-627. quiz 29.
79. Kepkep K., Tuncay Y.A., Goynumer G., Tutal E. Transvaginal sonography in the diagnosis of adenomyosis: which findings are most accurate?. Ultrasound Obstet Gynecol 2007, 30:341-345.
80. Meredith S., Sanchez-Ramos L., Kaunitz A. Diagnostic accuracy of transvaginal sonography. Am J Obstet Gynecol 2009, 201:107.e1-107.e6.
81. Ascher S.M., Arnold L.L., Patt R.H., et al. Adenomyosis: prospective comparison of MR imaging and transvaginal sonography. Radiology 1994, 190:803-806.
82. Atri M., Reinhold C., Mehio A.R., Chapman W.B., Bret P.M. Adenomyosis: US features with histologic correlation in an in-vitro study. Radiology 2000, 215:783-790.
83. Atzori E. Sonography for the diagnosis of adenomyosis. Ultrasound Obstet Gynecol 2003, 21:626-627.
84. Brosens J.J., de Souza N.M., Barker F.G., Paraschos T., Winston R.M. Endovaginal ultrasonography in the diagnosis of adenomyosis uteri: identifying the predictive characteristics. Br J Obstet Gynaecol 1995, 102:471-474.
85. Chiang C.H., Chang M.Y., Hsu J.J., et al. Tumor vascular pattern and blood flow impedance in the differential diagnosis of leiomyoma and adenomyosis by color Doppler sonography. J Assist Reprod Genet 1999, 16:268-275.
86. Fedele L., Bianchi S., Dorta M., Arcaini L., Zanotti F., Carinelli S. Transvaginal ultrasonography in the diagnosis of diffuse adenomyosis. Fertil Steril 1992, 58:94-97.
87. Meredith S.M., Sanchez-Ramos L., Kaunitz A.M. Diagnostic accuracy of transvaginal sonography for the diagnosis of adenomyosis: systematic review and metaanalysis. Am J Obstet Gynecol 2009, 201:107.e1-107.e6.
88. Reinhold C., Atri M., Mehio A., Zakarian R., Aldis A.E., Bret P.M. Diffuse uterine adenomyosis: morphologic criteria and diagnostic accuracy of endovaginal sonography. Radiology 1995, 197:609-614.
89. Reinhold C., McCarthy S., Bret P.M., et al. Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation. Radiology 1996, 199:151-158.
90. Sakhel K., Abuhamad A. Sonography of adenomyosis. J Ultrasound Med 2012, 31:805-808.
91. Vercellini P., Cortesi I., De Giorgi O., Merlo D., Carinelli S.G., Crosignani P.G. Transvaginal ultrasonography versus uterine needle biopsy in the diagnosis of diffuse adenomyosis. Hum Reprod 1998, 13:2884-2887.